Scholars Central

CommentaryPublished 26 Feb 2021

Key Biomarkers for Diabetes

Authors: Rances Blanco

Department of Quality Control, Center of Molecular Immunology, Playa, Cuba

Diagnostic Pathology: Open Access

Volume 6 · Issue 2 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recent studies shows how a new regulatory mechanism serves as an important biomarker for diabetes development as well as a possible therapeutic target for its prevention. The most significant pancreatic hormones in target tissues, such as the liver, are glucagon and insulin, which regulate proper glucose levels in response to food intake. Glucagon is secreted by pancreatic a-cells during fasting to increase blood glucose and protect the body from hypoglycemia. Glucagon has also been related to the development of diabetic hyperglycemia, primarily through the production of increased hepatic glucose, or HGP. Factor that affects transcription, glucagon acts by binding to a receptor known as a G-protein-coupled receptor, or GCGR.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Diagnostic Pathology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiagnostic Pathology: Open Access
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Rances Blanco”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels